References
- MorelandRBGoldsteinITraishASildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cellsLife Sci19986220PL309PL318
- BoolellMAllenMJBallardSASildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunctionInt J Impot Res19968247528858389
- BallardSAGingellCJTangKTurnerLAPriceMENaylorAMEffects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodi-esterase isozymesJ Urol19981596216421719598563
- PorstHRosenRPadma-NathanHThe efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trialInt J Impot Res200113419219911494074
- StarkSSachseRLiedlTVardenafil increases penile rigidity and tumescence in men with erectile dysfunction after a single oral doseEur Urol200140218119011528196
- KlotzTSachseRHeidrichAVardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic studyWorld J Urol2001191323911289568
- HellstromWJGittelmanMKarlinGVardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trialJ Androl200223676377112399521
- KeatingGMScottLJVardenafil: a review of its use in erectile dysfunctionDrugs200363232673270314636086
- VobigMAKlotzTStaakMBartz-SchmidtKUEngelmannUWalterPRetinal side-effects of sildenafilLancet19993539150375
- ZrennerENo cause for alarm over retinal side-effects of sildenafilLancet19993539150340341
- LuuJKChappelowAVMcculleyTJMarmorMFAcute effects of sildenafil on the electroretinogram and multifocal electroretinogramAm J Ophthalmol2001132338839411530053
- GabrieliCBRegineFVingoloEMRispoliEFabbriAIsidoriASubjective visual halos after sildenafil (Viagra) administration: Electroretinographic evaluationOphthalmology2001108587788111320016
- LatiesAZrennerEViagraZEViagra (sildenafil citrate) and ophthalmologyProg Retin Eye Res200221548550612207947
- JägleHJägleCSéreyLVisual short-term effects of Viagra: double-blind study in healthy young subjectsAm J Ophthalmol2004137584284915126148
- BeavoJACyclic nucleotide phosphodiesterases: functional implications of multiple isoformsPhysiol Rev19957547257487480160
- KinnearPRProposals for scoring and assessing the 100-hue testVision Res19701054234335312357
- BrigellMBachMBarberCKawasakiKKooijmanAGuidelines for calibration of stimulus and recording parameters used in clinical electrophysiology of vision. Calibration Standard Committee of the International Society for Clinical Electrophysiology of Vision (ISCEV)Doc Ophthalmol199895111410189178
- LatiesAMFraunfelderFTOcular safety of Viagra, (sildenafil citrate)Trans Am Ophthalmol Soc19999711512510703120
- YajimaTYajimaYKoppikerNGrunwaldJELatiesAMNo clinically important effects on intraocular pressure after short-term administration of sildenafil citrate (Viagra)Am J Ophthalmol2000129567567610844068
- SponselWEParisGSandovalSSSildenafil and ocular perfusionN Engl J Med200034222168010836891
- BirchDGTolerSMSwansonWHFishGELatiesAMA double-blind placebo-controlled evaluation of the acute effects of sildenafil citrate (Viagra) on visual function in subjects with early-stage age-related macular degenerationAm J Ophthalmol2002133566567211992864
- GrunwaldJEMetelitsinaTGrunwaldLEffect of sildenafil citrate (Viagra) on retinal blood vessel diameterAm J Ophthalmol2002133680981212036673
- GrunwaldJEJacobSSSiuKPiltzJDupontJAcute effects of sldenafil ctrate (Viagra) on intraocular pressure in open-angle glaucomaAm J Ophthalmol2001132687287411730651
- Nivison-SmithLZhuYWhathamASildenafil alters retinal function in mouse carriers of retinitis pigmentosaExp Eye Res2014128435625239397
- BehnDPotterMJSildenafil-mediated reduction in retinal function in heterozygous mice lacking the gamma-subunit of phosphodiesteraseInvest Ophthalmol Vis Sci200142252352711157892